As previous studies have shown increased expression of SGK1 in the P301S Tau transgenic mice and postmortem brain tissue from AD patients [10], we costained iPSC-derived cortical neurons from control subjects and AD patients for SGK1, MAP2, and DAPI (Fig. S2). This evidence concerns the gene MAP2 and Alzheimer disease.